OMIBREC Trademark

Trademark Overview


On Thursday, May 16, 2019, a trademark application was filed for OMIBREC with the United States Patent and Trademark Office. The USPTO has given the OMIBREC trademark a serial number of 79261303. The federal status of this trademark filing is REGISTERED as of Tuesday, February 11, 2020. This trademark is owned by Glaxo Group Limited. The OMIBREC trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
omibrec

General Information


Serial Number79261303
Word MarkOMIBREC
Filing DateThursday, May 16, 2019
Status700 - REGISTERED
Status DateTuesday, February 11, 2020
Registration Number5980340
Registration DateTuesday, February 11, 2020
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 26, 2019

Trademark Statements


Goods and ServicesPharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, June 25, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGlaxo Group Limited
Party Type30 - Original Registrant
Legal Entity Type11 - Company
AddressGB

Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type11 - Company
AddressGB

Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type11 - Company
AddressGB

Trademark Events


Event DateEvent Description
Friday, June 19, 2020FINAL DECISION TRANSACTION PROCESSED BY IB
Monday, June 1, 2020FINAL DISPOSITION NOTICE SENT TO IB
Sunday, May 31, 2020FINAL DISPOSITION PROCESSED
Monday, May 11, 2020FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, February 11, 2020REGISTERED-PRINCIPAL REGISTER
Tuesday, November 26, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 26, 2019PUBLISHED FOR OPPOSITION
Wednesday, November 6, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, October 22, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, October 22, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, October 22, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, October 22, 2019ASSIGNED TO LIE
Wednesday, October 16, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Saturday, October 12, 2019REFUSAL PROCESSED BY IB
Thursday, September 26, 2019NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Thursday, September 26, 2019REFUSAL PROCESSED BY MPU
Saturday, September 14, 2019NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Friday, September 13, 2019NON-FINAL ACTION WRITTEN
Saturday, August 31, 2019NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW
Friday, August 9, 2019NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Thursday, August 8, 2019NON-FINAL ACTION WRITTEN
Monday, July 29, 2019NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW
Saturday, July 6, 2019NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Friday, July 5, 2019NON-FINAL ACTION WRITTEN
Thursday, July 4, 2019ASSIGNED TO EXAMINER
Saturday, June 29, 2019APPLICATION FILING RECEIPT MAILED
Tuesday, June 25, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, June 20, 2019SN ASSIGNED FOR SECT 66A APPL FROM IB